The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Applications of Deuterium in Medicinal Chemistry
Abstract
The use of deuteration in medicinal chemistry has exploded in the past years, and the FDA has recently approved the first deuterium-labeled drug. Precision deuteration goes beyond the pure and simple amelioration of the pharmacokinetic parameters of a drug and might provide an opportunity when facing problems in terms of metabolism-mediated toxicity, drug interactions, and low bioactivation. The use of deuterium is even broader, offering the opportunity to lower the degree of epimerization, reduce the dose of coadministered boosters, and discover compounds where deuterium is the basis for the mechanism of action. Nevertheless, designing, synthesizing, and developing a successful deuterated drug is far from straightforward, and the translation from concept to practice is often unpredictable. This Perspective provides an overview of the recent developments of deuteration, with a focus on deuterated clinical candidates, and highlights both opportunities and challenges of this strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Production of Amino Acids Under Possible Primitive Earth Conditions
Miller, S. L. (1953) · Science · doi:10.1126/science.117.3046.528 · Cited by 3,522
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Isotopic compositions of the elements 1997 (Technical Report)
Rosman, K. J. R., & Taylor, P. D. P. (1998) · Pure and Applied Chemistry · doi:10.1351/pac199870010217 · Cited by 1,003
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881
Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences
Atzrodt, J., Derdau, V., Kerr, W. J., & Reid, M. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201704146 · Cited by 810
The Magnitude of the Primary Kinetic Isotope Effect for Compounds of Hydrogen and Deuterium.
Westheimer, F. H. (1961) · Chemical Reviews · doi:10.1021/cr60211a004 · Cited by 775
Using Deuterium in Drug Discovery: Leaving the Label in the Drug
Gant, T. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4007998 · Cited by 764
The Renaissance of H/D Exchange
Atzrodt, J., Derdau, V., Fey, T., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700039 · Cited by 720
Chiral Toxicology: It's the Same Thing…Only Different
Smith, S. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp097 · Cited by 602
Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds
Loh, Y. Y., Nagao, K., Hoover, A. J., Hesk, D., Rivera, N. R., Colletti, S. L., Davies, I. W., & MacMillan, D. W. C. (2017) · Science · doi:10.1126/science.aap9674 · Cited by 574
First deuterated drug approved
Schmidt, C. (2017) · Nature Biotechnology · doi:10.1038/nbt0617-493 · Cited by 466
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
Papp, K., Gordon, K., Thaçi, D., Morita, A., Gooderham, M., Foley, P., Girgis, I. G., Kundu, S., & Banerjee, S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806382 · Cited by 420
Hydrogen Tunneling Links Protein Dynamics to Enzyme Catalysis
Klinman, J. P., & Kohen, A. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-133623 · Cited by 388
Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options
Tanna, P., Strauss, R. W., Fujinami, K., & Michaelides, M. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-308823 · Cited by 370
Deuterated drugs draw heavier backing
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.63 · Cited by 258
Spiteller, G. (1998) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(98)00091-7 · Cited by 218
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety · doi:10.1002/da.22501 · Cited by 206
Controllable deuteration of halogenated compounds by photocatalytic D2O splitting
Liu, C., Chen, Z., Su, C., Zhao, X., Gao, Q., Ning, G.-H., Zhu, H., Tang, W., Leng, K., Fu, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02551-8 · Cited by 189
Liversidge Lecture. Recent advances in the study of kinetic hydrogen isotope effects
Bell, R. P. (1974) · Chemical Society Reviews · doi:10.1039/cs9740300513 · Cited by 182
Nelson, S. D., & Trager, W. F. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1481 · Cited by 164
Stable isotopes in clinical research: safety reaffirmed
Jones, P. J. H., & Leatherdale, S. T. (1991) · Clinical Science · doi:10.1042/cs0800277 · Cited by 161
Jia, H., Dai, G., Weng, J., Zhang, Z., Wang, Q., Zhou, F., Jiao, L., Cui, Y., Ren, Y., Fan, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500510f · Cited by 144
Structural basis of thalidomide enantiomer binding to cereblon
Mori, T., Ito, T., Liu, S., Ando, H., Sakamoto, S., Yamaguchi, Y., Tokunaga, E., Shibata, N., Handa, H., & Hakoshima, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19202-7 · Cited by 143
Hydrogen/Deuterium (H/D) Exchange Catalysis in Alkanes
Sattler, A. (2018) · ACS Catalysis · doi:10.1021/acscatal.7b04201 · Cited by 137
Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich’s ataxia
Abeti, R., Parkinson, M. H., Hargreaves, I. P., Angelova, P. R., Sandi, C., Pook, M. A., Giunti, P., & Abramov, A. Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.111 · Cited by 133
Charbel Issa, P., Barnard, A. R., Herrmann, P., Washington, I., & MacLaren, R. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506960112 · Cited by 124
Sharma, R., Strelevitz, T. J., Gao, H., Clark, A. J., Schildknegt, K., Obach, R. S., Ripp, S. L., Spracklin, D. K., Tremaine, L. M., & Vaz, A. D. N. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042770 · Cited by 119
Jacques, V., Czarnik, A. W., Judge, T. M., der Ploeg, L. H. T. V., & DeWitt, S. H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417832112 · Cited by 113
Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
Claassen, D. O., Carroll, B., Boer, L. M. D., Wu, E. Q., Ayyagari, R., Gandhi, S. K., & Stamler, D. A. (2017) · Journal of Clinical Movement Disorders · doi:10.1186/s40734-017-0051-5 · Cited by 107
Slaughter, L. M., Wolczanski, P. T., Klinckman, T. R., & Cundari, T. R. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000112q · Cited by 102
Demonstration of the Metabolic Pathway Responsible for Nevirapine-Induced Skin Rash
Chen, J., Mannargudi, B. M., Xu, L., & Uetrecht, J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800177k · Cited by 98
Deuterium Medicinal Chemistry Comes of Age
Tung, R. D. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0032 · Cited by 98
Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia
Zesiewicz, T. A., Heerinckx, F., Jager, R. D., Omidvar, O., Kilpatrick, M. W., Shaw, J., & Shchepinov, M. S. (2018) · Movement Disorders · doi:10.1002/mds.27353 · Cited by 93
Harbeson, S. L., Morgan, A. J., Liu, J. F., Aslanian, A. M., Nguyen, S., Bridson, G. W., Brummel, C. L., Wu, L., Tung, R. D., Pilja, L., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241497 · Cited by 92
Raefsky, S. M., Furman, R., Milne, G., Pollock, E., Axelsen, P., Mattson, M. P., & Shchepinov, M. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.024 · Cited by 90
Higashi, T., & Ogawa, S. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.04.033 · Cited by 88
Deuterated drugs; updates and obviousness analysis
Timmins, G. S. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1378350 · Cited by 87
Ma, L., Kaufman, Y., Zhang, J., & Washington, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178657 · Cited by 83
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia
Abeti, R., Uzun, E., Renganathan, I., Honda, T., Pook, M. A., & Giunti, P. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.015 · Cited by 83
Nag, S., Fazio, P., Lehmann, L. E., Kettschau, G., Heinrich, T. K., Thiele, A., Svedberg, M. M., Amini, N., Leesch, S., Catafau, A. M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161083 · Cited by 83
Shchepinov, M. S., Chou, V., Pollock, E. D., Langston, J. W., Cantor, C. R., Molinari, R. J., & Manning-Bog, A. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.07.020 · Cited by 82
Kaufman, Y., Ma, L., & Washington, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178640 · Cited by 78
Deuterated Clopidogrel Analogues as a New Generation of Antiplatelet Agents
Zhu, Y., Zhou, J., & Jiao, B. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300460t · Cited by 78
Elharram, A., Czegledy, N. M., Golod, M., Milne, G. L., Pollock, E. D., Bennett, B. M., & Shchepinov, M. S. (2017) · FEBS Journal · doi:10.1111/febs.14291 · Cited by 76
Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
Rodrigues, F. B., Duarte, G. S., Costa, J. N., Ferreira, J. J., & Wild, E. J. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12483 · Cited by 70
Kinetic Deuterium Isotope Effects in Cytochrome P450 Reactions
Guengerich, F. P. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.06.036 · Cited by 70
Kinetic deuterium isotope effects in cytochrome P450 oxidation reactions
Guengerich, F. P. (2013) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3031 · Cited by 67
Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane.
Sipes, I. G., Gandolfi, A. J., Pohl, L. R., Krishna, G., & Brown, B. R. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32240-8 · Cited by 66
Xu, G. Z., Lv, B., Roberge, J. Y., Xu, B., Du, J., Dong, J., Chen, Y., Peng, K., Zhang, L., Tang, X., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401780b · Cited by 65
Cerebral abnormalities in Friedreich ataxia: A review
Selvadurai, L. P., Harding, I. H., Corben, L. A., & Georgiou‐Karistianis, N. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.006 · Cited by 62
AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type
Garay, R. P., & Grossberg, G. T. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1267726 · Cited by 60
Uttamsingh, V., Gallegos, R., Liu, J. F., Harbeson, S. L., Bridson, G. W., Cheng, C., Wells, D. S., Graham, P. B., Zelle, R. E., & Tung, R. D. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223768 · Cited by 59
Knutson, D. E., Kodali, R., Divović, B., Treven, M., Stephen, M. R., Zahn, N. M., Dobričić, V., Huber, A. T., Meirelles, M. A., Verma, R. S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01664 · Cited by 59
Khan, A. J., Misenko, S. M., Thandoni, A., Schiff, D. S., Jhawar, S. R., Bunting, S. F., & Haffty, B. G. (2018) · Oncotarget · doi:10.18632/oncotarget.25383 · Cited by 58
Kerekes, A. D., Esposite, S. J., Doll, R. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1010995 · Cited by 57
Scott‐Stevens, P., Atack, J. R., Sohal, B., & Worboys, P. D. (2004) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.423 · Cited by 53
Manley, P. W., Blasco, F., Mestan, J., & Aichholz, R. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.038 · Cited by 51
Berbée, J. F. P., Mol, I. M., Milne, G. L., Pollock, E. D., Hoeke, G., Lütjohann, D., Monaco, C. G., Rensen, P. C. N., der Ploeg, L. H. T. V., & Shchepinov, M. S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.916 · Cited by 51
Zhang, M., Maeda, J., Ito, T., Okauchi, T., Ogawa, M., Noguchi, J., Suhara, T., Halldin, C., & Suzuki, K. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.11.058 · Cited by 49
Moon, B. S., Kim, B. S., Park, C., Jung, J. H., Lee, Y. W., Lee, H., Yoon, D., Lee, B. C., & Kim, S. E. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400556h · Cited by 43
A Decade of Deuteration in Medicinal Chemistry
Liu, J. F., Harbeson, S. L., Brummel, C. L., Tung, R. D., Silverman, R., & Doller, D. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.08.010 · Cited by 43
Halford, B. A. (2016) · C&EN Global Enterprise · doi:10.1021/cen-09427-cover · Cited by 42
Synthesis and Configurational Stability of (S)- and (R)-Deuteriothalidomides
Yamamoto, T., Tokunaga, E., Nakamura, S., Shibata, N., & Toru, T. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.110 · Cited by 40
O‘Ferrall, R. A. M. (2010) · Journal of Physical Organic Chemistry · doi:10.1002/poc.1738 · Cited by 37
Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide
Jiang, J., Pang, X., Dai, X., Diao, X., Chen, X., Zhong, D., Chen, Y., Li, L., & Wang, Y. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s111352 · Cited by 37
Effect of N‐methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide
Pang, X., Peng, L., & Chen, Y. (2017) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3516 · Cited by 36
Inside the isomers: the tale of chiral switches
Somogyi, A. A., Bochner, F., & Foster, D. J. R. (2004) · Australian Prescriber · doi:10.18773/austprescr.2004.039 · Cited by 35
Malmlöf, T., Ottosson, D. R., Alken, R.-G., Schneider, F., Svensson, T. H., Cenci, M. A., & Schilström, B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.018 · Cited by 32
Braman, V. M., Graham, P. B., Cheng, C., Turnquist, D. J., Harnett, M. D., Sabounjian, L., & Shipley, J. E. (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.3 · Cited by 30
Sabounjian, L., Graham, P. B., Wu, L., Braman, V. M., Cheng, C., Liu, J. X., Shipley, J. E., Neutel, J., & Dao, M. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.241 · Cited by 27
Pang, X., Wang, Y., & Chen, Y. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.071 · Cited by 27
Control of lysyl oxidase activity through site-specific deuteration of lysine
Pestov, N. B., Okkelman, I. A., Shmanai, V. V., Hurski, A. L., Giaccia, A. J., & Shchepinov, M. S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.018 · Cited by 22
Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine.
Darland, G. K., Hajdu, R., Kropp, H., Kahan, F. M., Walker, R. W., & VandenHeuvel, W. J. A. (1986) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08992-5 · Cited by 22
Xie, J., Gillooly, K. M., zhang, Y., et al. (2018) · Gastroenterology · doi:10.1016/s0016-5085(18)34439-1 · Cited by 22
Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward
Alex, A., Smith, D. A., & Harris, C. (2015) · Cited by 18
Miller–Urey Spark‐Discharge Experiments in the Deuterium World
Cooper, G. J. T., Surman, A. J., McIver, J., Colón‐Santos, S. M., Gromski, P. S., Buchwald, S., Suárez-Marina, I., & Cronin, L. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610837 · Cited by 17
Homochiral Drug Design and Development by Racemization
Ali, I. (2007) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620707781662835 · Cited by 12
Cited by
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
Recent Developments for the Deuterium and Tritium Labeling of Organic Molecules
Kopf, S., Bourriquen, F., Li, W., Neumann, H., Junge, K., & Beller, M. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00795 · Cited by 649
Deuterium in drug discovery: progress, opportunities and challenges
Di Martino, R. M. C., Maxwell, B. D., & Pirali, T. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00703-8 · Cited by 539
Self-citationBorrowing Hydrogen for Organic Synthesis
Reed-Berendt, B. G., Latham, D. E., Dambatta, M. B., & Morrill, L. C. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00125 · Cited by 485
Metadata
- Authors
- Pirali, T., Serafini, M., Cargnin, S., & Genazzani, A. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-01-14
- Volume
- 62
- Issue
- 11
- Pages
- 5276-5297
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2909275830
- Cited by
- 855
- References
- 79
- FWCI
- 27.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.